Literature DB >> 26622460

Correlation between the protein expression of A-kinase anchor protein 95, cyclin D3 and AKT and pathological indicators in lung cancer tissues.

Xiuyi Yu1, Yangyang Yuan2, Xuehong Zhi2, Bogang Teng2, Xiaoxuan Chen2, Qian Huang2, Yuexin Chen2, Zhiyu Guan3, Yongxing Zhang2.   

Abstract

The aim of the present study was to investigate the correlation between the protein expression of A-kinase anchor protein 95 (AKAP95), cyclin D3 and AKT with pathological indicators in lung cancer tissues. Immunohistochemistry was used to detect the protein expression levels of the proteins in 51 lung cancer tissue samples and 15 pericarcinoma tissue samples. The percentage of cyclin D3 positive samples in the lung cancer and pericarcinoma tissues was 68.63 and 28.57%, respectively, and the difference was statistically significant (P<0.01). However, cyclin D3 expression was not shown to correlate with differentiation grade, histological type or lymph node metastasis. In addition, the percentage of AKT positive samples in the cancer and pericarcinoma tissues was 76.47 and 38.46%, respectively, and the difference was statistically significant (P<0.05). AKT expression was found to significantly correlate with the grade of cancer tissue differentiation (P<0.05); however, no correlations were observed with histological type or lymph node metastasis (P>0.05). AKAP95 expression was shown to correlate with cyclin D3 and AKT expression in the lung cancer tissue (P<0.05); however, there was no correlation between cyclin D3 and AKT expression. The present study provided evidence suggesting that AKAP95 may have a role in regulation of the cell cycle.

Entities:  

Keywords:  A-kinase anchor protein 95; AKT; biomarkers; cyclin D3; diagnosis; lung cancer; pathology

Year:  2015        PMID: 26622460      PMCID: PMC4533126          DOI: 10.3892/etm.2015.2637

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  20 in total

Review 1.  A-kinase anchoring proteins: scaffolding proteins in the heart.

Authors:  Dario Diviani; Kimberly L Dodge-Kafka; Jinliang Li; Michael S Kapiloff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

2.  Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.

Authors:  M B Møller; O Nielsen; N T Pedersen
Journal:  Am J Clin Pathol       Date:  2001-03       Impact factor: 2.493

3.  Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas.

Authors:  I R Bukholm; G Bukholm; J M Nesland
Journal:  Int J Cancer       Date:  2001-07-15       Impact factor: 7.396

4.  Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study.

Authors:  P S Hiscott; I Grierson; D McLeod
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

5.  Burkitt lymphoma: much more than MYC.

Authors:  David Dominguez-Sola; Riccardo Dalla-Favera
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

6.  Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity.

Authors:  Szabolcs Fatrai; Lynda Elghazi; Norman Balcazar; Corentin Cras-Méneur; Irina Krits; Hiroaki Kiyokawa; Ernesto Bernal-Mizrachi
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

7.  A-kinase-anchoring protein 95 functions as a potential carrier for the nuclear translocation of active caspase 3 through an enzyme-substrate-like association.

Authors:  Shinji Kamada; Ushio Kikkawa; Yoshihide Tsujimoto; Tony Hunter
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

8.  Expression of cyclin genes in human gastric cancer and in first degree relatives.

Authors:  Jun Yu; Stephan Miehlke; Matthias P A Ebert; Daniel Szokodi; B Wehvnignh; Peter Malfertheiner; G Ehninger; Ekkehard Bayerdoerffer
Journal:  Chin Med J (Engl)       Date:  2002-05       Impact factor: 2.628

9.  Immunophenotypic profiling of nonsmall cell lung cancer progression using the tissue microarray approach.

Authors:  Judit Papay; Tibor Krenacs; Judit Moldvay; Eva Stelkovics; Jozsef Furak; Bela Molnar; Laszlo Kopper
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-03

10.  [Relationship between AKAP95, cyclin E1, cyclin D1, and clinicopathological parameters in lung cancer tissue].

Authors:  Su-xian Hu; Xiang-yu Kong; Yang-yang Yuan; Bo-gang Teng; Xue-hong Zhi; Wen-xin Zhuang; Xiu-yi Yu; Wen-zhi Liu; Yong-xing Zhang
Journal:  Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi       Date:  2013-12
View more
  5 in total

1.  Expression of AKT and p-AKT protein in lung adenocarcinoma and its correlation with PD-L1 protein and prognosis.

Authors:  Zhi-Ying Hu; Wan-Yi Huang; Lei Zhang; Bo Huang; Shu-Chen Chen; Xiao-Ling Li
Journal:  Ann Transl Med       Date:  2020-09

2.  Epac1, PDE4, and PKC protein expression and their association with AKAP95, Cx43, and cyclinD2/E1 in breast cancer tissues.

Authors:  Ping Huang; Qian Sun; Wenxin Zhuang; Kuan Peng; Dai Wang; Youliang Yao; Dongbei Guo; Lu Zhang; Chuhan Shen; Mengyun Sun; Chaoying Tang; Bogang Teng; Yongxing Zhang
Journal:  Thorac Cancer       Date:  2017-07-29       Impact factor: 3.500

3.  Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells.

Authors:  Ya-Hui Chen; Shun-Fa Yang; Chueh-Ko Yang; Horng-Der Tsai; Tze-Ho Chen; Ming-Chih Chou; Yi-Hsuan Hsiao
Journal:  Mol Med Rep       Date:  2020-11-25       Impact factor: 2.952

4.  Chemoprevention of 4NQO-Induced Mouse Tongue Carcinogenesis by AKT Inhibitor through the MMP-9/RhoC Signaling Pathway and Autophagy.

Authors:  Panpan Yin; Jiahui Chen; Yanlin Wu; Feng Gao; Jinlin Wen; Wenbin Zhang; Ying Su; Xinyan Zhang
Journal:  Anal Cell Pathol (Amst)       Date:  2022-10-05       Impact factor: 4.133

5.  Dynamic changes in protein interaction between AKAP95 and Cx43 during cell cycle progression of A549 cells.

Authors:  Xiaoxuan Chen; Xiangyu Kong; Wenxin Zhuang; Bogang Teng; Xiuyi Yu; Suhang Hua; Su Wang; Fengchao Liang; Dan Ma; Suhui Zhang; Xuan Zou; Yue Dai; Wei Yang; Yongxing Zhang
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.